Autolus Therapeutics Ltd reported 27.96M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
AstraZeneca USD 5.01B 1.42B Jun/2025
Autolus Therapeutics Ltd 27.96M 1.58M Jun/2025
Hikma Pharmaceutical USD 288M 8M Dec/2024
Novartis USD 3.44B 384M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Silence Therapeutics 5.6M 312K Sep/2024